Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51

BACKGROUND: Chemotherapy is a standard therapeutic regimen to treat triple-negative breast cancer (TNBC); however, chemotherapy alone does not result in significant improvement and often leads to drug resistance in patients. In contrast, combination therapy has proven to be an effective strategy for...

全面介紹

Na minha lista:
書目詳細資料
發表在:Breast Cancer Res
Main Authors: Lee, Jung Ok, Kang, Min Ju, Byun, Won Seok, Kim, Shin Ae, Seo, Il Hyeok, Han, Jeong Ah., Moon, Ji Wook, Kim, Ji Hae, Kim, Su Jin, Lee, Eun Jung, In Park, Serk, Park, Sun Hwa, Kim, Hyeon Soo
格式: Artigo
語言:Inglês
出版: BioMed Central 2019
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6805313/
https://ncbi.nlm.nih.gov/pubmed/31640742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-019-1204-2
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍